paxilline has been researched along with Muscular Weakness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Zahrani, KN; Belkina, N; Dufresne, S; Frenette, J; Labrèche, C; Patino-Lopez, G; Pryce, BR; Sabourin, LA; Shaw, S | 1 |
1 other study(ies) available for paxilline and Muscular Weakness
Article | Year |
---|---|
Deletion of the Ste20-like kinase SLK in skeletal muscle results in a progressive myopathy and muscle weakness.
Topics: Animals; Cells, Cultured; Focal Adhesions; Gene Deletion; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle Development; Muscle Fibers, Skeletal; Muscle Weakness; p38 Mitogen-Activated Protein Kinases; Paxillin; Protein Serine-Threonine Kinases; Regeneration | 2017 |